Abstract

RNA polymerase II transcribes both protein coding and non-coding RNA genes and, in yeast, different mechanisms terminate transcription of the two gene types. Transcription termination of mRNA genes is intricately coupled to cleavage and polyadenylation, whereas transcription of small nucleolar (sno)/small nuclear (sn)RNA genes is terminated by the RNA-binding proteins Nrd1, Nab3 and Sen1. The existence of an Nrd1-like pathway in humans has not yet been demonstrated. Using the U1 and U2 genes as models, we show that human snRNA genes are more similar to mRNA genes than yeast snRNA genes with respect to termination. The Integrator complex substitutes for the mRNA cleavage and polyadenylation specificity factor complex to promote cleavage and couple snRNA 3′-end processing with termination. Moreover, members of the associated with Pta1 (APT) and cleavage factor I/II complexes function as transcription terminators for human snRNA genes with little, if any, role in snRNA 3′-end processing. The gene-specific factor, proximal sequence element-binding transcription factor (PTF), helps clear the U1 and U2 genes of nucleosomes, which provides an easy passage for pol II, and the negative elongation factor facilitates termination at the end of the genes where nucleosome levels increase. Thus, human snRNA genes may use chromatin structure as an additional mechanism to promote efficient transcription termination in vivo.

Highlights

  • Transcription termination is the final stage of the transcription cycle when the RNA polymerase stops transcribing and disengages from the DNA template. little is known about the mechanism(s) by which RNA polymerase II is released, several factors are implicated in the termination process [1,2,3,4]

  • To investigate the mechanism of termination of transcription of the human snRNA genes, we examined the requirement for Xrn2, which is implicated in the ‘torpedo’ mechanism, and Senataxin, which is the human homologue of Sen1

  • Pol II can choose between two distinct pathways to terminate transcription in vivo

Read more

Summary

Introduction

Little is known about the mechanism(s) by which RNA polymerase II (pol II) is released, several factors are implicated in the termination process [1,2,3,4]. As Pcf associates with RNA, it is thought to tether the polymerase to the transcript, exerting enough force to reduce its processivity, which leads to termination of transcription [10,11,12]. 30-end processing factors, including cleavage and polyadenylation specificity factor (CPSF), cleavage stimulatory factor (CstF) and members of the Associated with Pta (APT) complex, including Ssu, promote cleavage of the RNA at the poly A site, creating an entry site for the 50–30 exonuclease, Rat. Rat degrades the downstream RNA and this is thought to help dissociate the elongation complex [13]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call